Clinical Utility of Magnetic Resonance Imaging Biomarkers for Identifying Nonalcoholic Steatohepatitis Patients at High Risk of Progression: A Multicenter Pooled Data and Meta-Analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Utility of Magnetic Resonance Imaging Biomarkers for Identifying Nonalcoholic Steatohepatitis Patients at High Risk of Progression: A Multicenter Pooled Data and Meta-Analysis
Authors
Keywords
Liver, MultiScan, cT1, PDFF, NAFLD, Noninvasive, Quantitative MRI
Journal
Clinical Gastroenterology and Hepatology
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-10-08
DOI
10.1016/j.cgh.2021.09.041
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Disease burden and economic impact of diagnosed non‐alcoholic steatohepatitis (nash) in five european countries in 2018: A cost‐of‐illness analysis
- (2021) Jörn M. Schattenberg et al. LIVER INTERNATIONAL
- Quantitative multiparametric magnetic resonance imaging can aid non-alcoholic steatohepatitis diagnosis in a Japanese cohort
- (2021) Kento Imajo et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Correlations Between MRI Biomarkers PDFF and cT1 With Histopathological Features of Non-Alcoholic Steatohepatitis
- (2021) Andrea Dennis et al. Frontiers in Endocrinology
- Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort
- (2021) Stephen A. Harrison et al. JOURNAL OF HEPATOLOGY
- Comparison between magnetic resonance and ultrasound-derived indicators of hepatic steatosis in a pooled NAFLD cohort
- (2021) Cayden Beyer et al. PLoS One
- Hepatic Steatosis, Rather Than Underlying Obesity, Increases the Risk of Infection and Hospitalization for COVID-19
- (2021) Adriana Roca-Fernández et al. Frontiers in Medicine
- Incidence of Complications from Percutaneous Biopsy in Chronic Liver Disease: A Systematic Review and Meta-Analysis
- (2021) Helena B. Thomaides-Brears et al. DIGESTIVE DISEASES AND SCIENCES
- Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial
- (2021) Stephen A. Harrison et al. NATURE MEDICINE
- Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases
- (2021) Mohammed Eslam et al. Lancet Gastroenterology & Hepatology
- Systematic Literature Review and Critical Appraisal of Health Economic Models Used in Cost-Effectiveness Analyses in Non-Alcoholic Steatohepatitis: Potential for Improvements
- (2020) Pierre Johansen et al. PHARMACOECONOMICS
- FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study
- (2020) Philip N Newsome et al. Lancet Gastroenterology & Hepatology
- Driving NASH forward using the FAST score but obey the traffic lights
- (2020) Nabil Noureddin et al. HEPATOLOGY
- Prognostic value of multiparametric magnetic resonance imaging, transient elastography and blood‐based fibrosis markers in patients with chronic liver disease
- (2020) Arjun N.A. Jayaswal et al. LIVER INTERNATIONAL
- Multiparametric MR mapping in clinical decision-making for diffuse liver disease
- (2020) Helena B. Thomaides-Brears et al. Abdominal Radiology
- Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort
- (2020) Tracey G Simon et al. GUT
- Multiparametric MRI in Patients With Nonalcoholic Fatty Liver Disease
- (2020) Jelte J. Schaapman et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- A composite biomarker using multiparametric magnetic resonance imaging and blood analytes accurately identifies patients with non-alcoholic steatohepatitis and significant fibrosis
- (2020) Andrea Dennis et al. Scientific Reports
- The Association of Histologic and Non-invasive Tests with Adverse Clinical and Patient-Reported Outcomes in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis (NASH)
- (2020) Zobair M. Younossi et al. GASTROENTEROLOGY
- MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis
- (2020) Jinho Jung et al. GUT
- NGM 282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients with Nonalcoholic Steatohepatitis
- (2019) Stephen A. Harrison et al. HEPATOLOGY
- The diagnosis of nonalcoholic fatty liver disease should carry important prognostic information
- (2019) Ian A Rowe et al. Nature Reviews Gastroenterology & Hepatology
- Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver disease
- (2019) Katharina Staufer et al. United European Gastroenterology Journal
- Acetyl-CoA Carboxylase Inhibitor GS-0976 for 12 Weeks Reduces Hepatic De Novo Lipogenesis and Steatosis in Patients With Nonalcoholic Steatohepatitis
- (2018) Eric J. Lawitz et al. Clinical Gastroenterology and Hepatology
- Association Between Magnetic Resonance Imaging-Proton Density Fat Fraction and Liver Histology Features in Patients With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis
- (2018) Benjamin Wildman-Tobriner et al. GASTROENTEROLOGY
- ADAPT: An algorithm incorporating PRO-C3 accurately identifies patients with NAFLD and advanced fibrosis
- (2018) Samuel J. Daniels et al. HEPATOLOGY
- Pharmacotherapy for NASH: Current and emerging
- (2018) Monica A. Konerman et al. JOURNAL OF HEPATOLOGY
- Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-Analysis
- (2018) Takeshi Yokoo et al. RADIOLOGY
- Multiparametric magnetic resonance imaging for quantitation of liver disease: a two-centre cross-sectional observational study
- (2018) Natasha McDonald et al. Scientific Reports
- Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial
- (2018) Stephen A. Harrison et al. PLoS One
- Agreement Between Magnetic Resonance Imaging Proton Density Fat Fraction Measurements and Pathologist-Assigned Steatosis Grades of Liver Biopsies From Adults With Nonalcoholic Steatohepatitis
- (2017) Michael S. Middleton et al. GASTROENTEROLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
- (2017) Chris Estes et al. HEPATOLOGY
- Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis
- (2017) Parambir S. Dulai et al. HEPATOLOGY
- Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity
- (2017) Michael Pavlides et al. LIVER INTERNATIONAL
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease
- (2016) Michael Pavlides et al. JOURNAL OF HEPATOLOGY
- Decision analytic model of the diagnostic pathways for patients with suspected non-alcoholic fatty liver disease using non-invasive transient elastography and multiparametric magnetic resonance imaging
- (2016) Laurence Blake et al. BMJ Open
- Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE
- (2015) I. Doycheva et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
- (2015) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up
- (2015) Mattias Ekstedt et al. HEPATOLOGY
- Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials
- (2013) Mazen Noureddin et al. HEPATOLOGY
- Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease
- (2013) Rajarshi Banerjee et al. JOURNAL OF HEPATOLOGY
- Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD
- (2012) Z. Permutt et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Nonalcoholic Fatty Liver Disease: Pathologic Patterns and Biopsy Evaluation in Clinical Research
- (2012) David Kleiner et al. SEMINARS IN LIVER DISEASE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started